SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
44 hedge funds and large institutions have $1.2M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
97% less capital invested
Capital invested by funds: $40.8M → $1.2M (-$39.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
$55K
Puts
$355K
Top Buyers
| 1 | +$236K | |
| 2 | +$180K | |
| 3 | +$166K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$129K |
| 5 |
HF
HRT Financial
New York
|
+$105K |
Top Sellers
| 1 | -$5.56M | |
| 2 | -$4.45M | |
| 3 | -$3.84M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.16M |
| 5 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$2.78M |